Assenagon Asset Management

Assenagon Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Assenagon Asset Management’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell
2021 Q3	$27.2M	Buy
2021 Q2	$21.3M	Buy
2021 Q1	$388K	Sell
2020 Q4	$2.94M	Sell
2020 Q3	$2.65M	Buy
2020 Q2	–	Sell
2020 Q1	$3.52M	Buy
2019 Q2	–	Sell
2019 Q1	$4.5M	Buy